« Previous
Next »
Journal of Vascular Surgery
Volume 51, Issue 1
, Pages 165-173
, January 2010
Endothelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia in mice
References
- . Critical limb ischemia: nothing to give at the office?. Ann Intern Med. 1999;130:442–444
- . Arteriogenesis: the development and growth of collateral arteries. Microcirculation. 2003;10:83–97
- . Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol. 2002;34:775–787
- . Flow, NO, and atherogenesis. Proc Natl Acad Sci. 2003;100:768–770
- Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hindlimb. Arterioscler Thromb Vasc Biol. 2004;24:1664–1668
- Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol. 2003;284:H1422–H1428
- Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967
- . Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343–353
- Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004;94:678–685
- Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med. 2006;12:557–567
- Endothelial nitric oxide synthase activity is essential for vasodilation during blood flow recovery but not for arteriogenesis. Arterioscler Thromb Vasc Biol. 2007;27:1–8
- Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Mede. 2003;9:1370–1376
- Endothelial NOS is required for SDF-1α/CXCR4-mediated peripheral endothelial adhesion of c-Kit+ bone marrow stem cells. Lab Invest. 2008;88:58–69
- . Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. Arterioscler Thromb Vasc Biol. 2008;28:217–222
- VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med. 2008;86:1221–1232
- . The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia. J Vasc Surg. 2005;41:312–320
- Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567–2568
- The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res. 2006;99:656–662
- Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci. 2005;102:10999–11004
- . Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arterioscler Thromb Vasc Biol. 2002;22:1279–1285
- . Overexpression of endothelial nitric oxide synthase increases skeletal muscled blood flow and oxygenation in severe rat hind limb ischema. J Vasc Surg. 2003;38:820–826
- Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol. 2007;27:2310–2318
- . Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593–615
- . A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res. 2004;94:573–574
- . Biochemical evidence of impaired nitric oxide synthesis in patients with peripheral arterial disease. Circulation. 1997;95:2068–2073
- The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation. 2003;107:1359–1365
- Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002;105:788–793
- Gene transfer of stromal cell-derived factor-1a enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation. 2004;109:2454–2461
- Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res. 2006;99:715–722
This work was funded by HL75353 to Dr Messina.
Competition of interest: none.
The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.
PII: S0741-5214(09)01686-3
doi: 10.1016/j.jvs.2009.08.045
© 2010 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular Surgery
Volume 51, Issue 1
, Pages 165-173
, January 2010
